| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/09/2007 | US7160872 Methods to treat conditions mediated by chemokine receptors |
| 01/09/2007 | US7160870 Thrombopoietin mimetics |
| 01/09/2007 | CA2375372C Mutual prodrugs of amlodipine and atorvastatin |
| 01/09/2007 | CA2338276C Fkbp inhibitors |
| 01/09/2007 | CA2196271C Quinolone- or naphthyridonecarboxylic acid derivative or salt thereof |
| 01/09/2007 | CA2144293C Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
| 01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| 01/04/2007 | WO2007002764A2 Di-substituted oxadiazoles as cxc-chemokine receptor ligands |
| 01/04/2007 | WO2007002637A1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 01/04/2007 | WO2007002563A1 Imidazole based lxr modulators |
| 01/04/2007 | WO2007002559A1 Pyrazole based lxr modulators |
| 01/04/2007 | WO2007002557A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/04/2007 | WO2007002254A2 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 01/04/2007 | WO2007002057A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 01/04/2007 | WO2007001975A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | WO2007001249A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 01/04/2007 | WO2007000464A1 Novel 3-aza-spiro[5.5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/04/2007 | WO2007000289A1 Nitro-substituted hydroxyindoles,their use as inhibitors of phosphodiesterase 4, and processes for preparing them |
| 01/04/2007 | WO2007000248A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 01/04/2007 | WO2007000246A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 01/04/2007 | WO2007000240A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 01/04/2007 | WO2006125194A3 Piperazine derivatives and their uses as therapeutic agents |
| 01/04/2007 | WO2006123113A3 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors |
| 01/04/2007 | WO2006110816A3 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
| 01/04/2007 | WO2006107964A3 Processes to prepare 6-phenethyl-octahydro-pyrrolo [2 , 3-c] pyridine and related compounds |
| 01/04/2007 | WO2006106423A3 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| 01/04/2007 | WO2006039325A3 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 01/04/2007 | WO2006020598A3 Amido compounds and their use as pharmaceuticals |
| 01/04/2007 | WO2006004684A8 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 01/04/2007 | WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors |
| 01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/04/2007 | WO2005012297A9 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 01/04/2007 | US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems |
| 01/04/2007 | US20070004779 Process for producing crystal |
| 01/04/2007 | US20070004778 New salts of omeprazole and esomeprazole i |
| 01/04/2007 | US20070004775 such as methyl-(2S)-2-[(3,5-dichloroisonicotinoyl)amino]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoate, that are potent and selective inhibitors of alpha 4 integrins(VLA-4), having oral bioavailability, low clearance and high absorption, used for the treatment of VLA-4 dependent inflammatory diseases |
| 01/04/2007 | US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 01/04/2007 | US20070004763 Aminoquinoline and aminoquinazoline kinase modulators |
| 01/04/2007 | US20070004758 [2-Alkyl-3-(phenylaminocarbonyl)-4-(4-pyrimidinyl, 5-pyrrolyl, or 4-pyridinyl)-5-(p-fluorophenyl)pyrrol-1-yl]dihydroxyalkanoic acids and 6-alkyl-gamma-hydroxyvalerolactones; antiinflammatory agents; carciovascular disorders; P38 map kinase inhibitors |
| 01/04/2007 | US20070004749 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 01/04/2007 | US20070004746 Imatinib mesylate; antitumor agent |
| 01/04/2007 | US20070004743 Intranasal administration of mc4-r agonists |
| 01/04/2007 | US20070004742 Arylpiperazinyl compounds |
| 01/04/2007 | US20070004736 Imidazole derivative, process for producing the same, and use |
| 01/04/2007 | US20070004729 Methods and compositions of novel triazine compounds |
| 01/04/2007 | US20070004677 purinergic receptor antagonists such as N-(2-(2-tert-butylphenoxy)pyridin-3-yl)cinnamamide, used for modulation of platelet reactivity; anticoagulants |
| 01/04/2007 | DE102005030522A1 Salz des Embusartans Salt of the Embusartans |
| 01/04/2007 | CA2613607A1 Di-substituted oxadiazoles as cxc-chemokine receptor ligands |
| 01/04/2007 | CA2613522A1 Imidazole based lxr modulators |
| 01/04/2007 | CA2613517A1 Pyrazole based lxr modulators |
| 01/04/2007 | CA2612601A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 01/04/2007 | CA2611971A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 01/04/2007 | CA2611953A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 01/04/2007 | CA2611552A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/04/2007 | CA2611295A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 01/04/2007 | CA2611128A1 Novel indoline compounds |
| 01/04/2007 | CA2610959A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | CA2609957A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 01/03/2007 | EP1739085A1 Cosmetic composition containing a double para-phenylenediamines joined by an aromatic group and use in dyeing |
| 01/03/2007 | EP1737925A1 New organic luminescent element |
| 01/03/2007 | EP1737863A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
| 01/03/2007 | EP1737860A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments |
| 01/03/2007 | EP1737852A2 Polycyclic pyridines as potassium ion channel modulators |
| 01/03/2007 | EP1737851A1 Tetrahydrobenzazepine derivatives as modulators of dopamine d3 receptors (antipsychotic agents) |
| 01/03/2007 | EP1737845A2 Disalt inhibitors of il-12 production |
| 01/03/2007 | EP1737844A2 Bicyclic anthranilamide derivatives useful as insecticides |
| 01/03/2007 | EP1737843A1 Inhibitors of akt activity |
| 01/03/2007 | EP1737842A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs |
| 01/03/2007 | EP1737841A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 01/03/2007 | EP1737840A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 01/03/2007 | EP1737839A1 Novel alkyne compounds having an mch-antagonistic effect and medicaments containing said compounds |
| 01/03/2007 | EP1737838A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
| 01/03/2007 | EP1737831A1 Neurologically-active compounds |
| 01/03/2007 | EP1737830A1 Tri-substituted ureas as cytokine inhibitors |
| 01/03/2007 | EP1737827A1 Process for preparing pyridazinone compounds |
| 01/03/2007 | EP1737824A2 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds |
| 01/03/2007 | EP1737823A2 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds |
| 01/03/2007 | EP1737463A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737462A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737453A2 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders |
| 01/03/2007 | EP1737451A2 Monocyclic heterocycles as kinase inhibitors |
| 01/03/2007 | EP1737414A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain |
| 01/03/2007 | EP1737297A2 Imidazole compounds |
| 01/03/2007 | EP1562925B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/03/2007 | EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 01/03/2007 | EP1265850B1 Insecticidal anthranilamides |
| 01/03/2007 | EP1223944B1 Thrombopoietin mimetics |
| 01/03/2007 | EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 01/03/2007 | CN1890383A Hinge core mimetibodies, compositions, methods and uses |
| 01/03/2007 | CN1890234A Novel quinoline derivatives |
| 01/03/2007 | CN1890225A Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 01/03/2007 | CN1890224A 6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose)polymerase inhibitors |
| 01/03/2007 | CN1890223A Capsaicin receptor agonists |
| 01/03/2007 | CN1890218A Tubulin inhibitors |
| 01/03/2007 | CN1890217A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B |
| 01/03/2007 | CN1890216A Carboxamide derivatives |
| 01/03/2007 | CN1890215A Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/03/2007 | CN1890213A Process for the preparation of n-amino substituted heterocyclic compounds |
| 01/03/2007 | CN1890208A Opioid receptor antagonists |